Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03579654 |
|
Recruitment Status : Unknown
Verified March 2019 by OncBioMune Pharmaceuticals.
Recruitment status was: Not yet recruiting
First Posted : July 6, 2018
Last Update Posted : March 6, 2019
|
Sponsor:
OncBioMune Pharmaceuticals
Information provided by (Responsible Party):
OncBioMune Pharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | February 28, 2021 |
| Estimated Study Completion Date : | June 30, 2022 |